98%
921
2 minutes
20
Background: The evolution of ischemic stroke is different accordin'g to sex and is one of the main causes of death in women. Previous studies have shown that women are less likely to receive acute treatment, and stroke center type is an important predictor of door-to-needle times. We investigated whether women are attended in a similar way to men in the telestroke network with specialized stroke physicians.
Methods: A prospective registry of ischemic strokes recorded in the centralized Andalusian telestroke network was analyzed, focusing on sex differences. Demographic data, clinical characteristics, neuroimaging data, treatment intervals, follow-up visits, and clinical outcomes were collected.
Results: A total of 3009 suspected stroke patients were attended to in the telestroke network from 2019 to 2023, of which 42.74% were women. Women were older ( < 0.001) and less independent upon arrival ( = 0.006) than men. There was no difference in the treatment received or in the treatment time intervals between the groups. Importantly, there was no difference in modified Rankin scale scores at 3 months between sexes. At 3 months post-stroke follow-up, women had fewer imaging tests ( = 0.018) and fewer outpatient visits ( < 0.001) than men.
Conclusions: No significant difference between men and women has been found in the acute treatment of stroke in a large telestroke network. However, the same is not true for the follow-up and management of patients after the acute phase. This fact supports that strict adherence to protocols and specialization of care lead to equal care that avoids sex differences in stroke treatment and functional outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249131 | PMC |
http://dx.doi.org/10.1089/heq.2023.0175 | DOI Listing |
Stroke
September 2025
Hospital Israelita Albert Einstein, São Paulo, Brazil (J.B.C.d.A., G.S.S.).
The global transition to digital health offers a critical opportunity to transform health care delivery, particularly in low- and middle-income countries. Stroke care exemplifies the need for timely, coordinated, and longitudinal management across health systems. Although substantial progress has been achieved, low- and middle-income countries continue to encounter persistent challenges, including infrastructural deficiencies, digital inequity, fragmented governance structures, and limitations within the health care workforce.
View Article and Find Full Text PDFStroke
September 2025
Hospital Israelita Albert Einstein and Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, Brazil (G.S.S.).
Neurology
September 2025
Department of Neurology, State University of New York Upstate Medical University, Syracuse.
Background And Objectives: There is paucity of data on the population-level incidence of moyamoya angiopathy (MMA) in the United States. The aim of this study was to estimate sex-specific, age-specific, and race-specific incidence of MMA in the United States over the period 2011-2020.
Methods: We used the State Ambulatory Surgery, Emergency, and Inpatient Databases of Florida (2005-2020), Georgia (2010-2020), Maryland (2012-2020), and New York (2005-2020) to conduct a retrospective study.
J Stroke Cerebrovasc Dis
October 2025
Department of Neurology, Emory University Hospital, Atlanta, GA, USA. Electronic address:
Background: Alteplase (tPA) and Tenecteplase (TNK) are both FDA-approved thrombolytic agents for acute ischemic stroke (AIS) treatment. While TNK showed efficacy and safety in the randomized clinical trials, its real-world utilization and effectiveness in rural populations remain key areas for post-approval evaluation. In August 2023 our academic institution, serving as a statewide telestroke network hub, implemented a system-wide transition from tPA to TNK.
View Article and Find Full Text PDFCan J Neurol Sci
August 2025
Department of Industrial Engineering, Dalhousie University, Halifax, NS, Canada.
Background: Stroke is a devastating disease, but the disability due to stroke can be avoided or reduced through timely access to treatment and care. This study surveyed all designated stroke centres across Canada to better understand the national acute stroke treatment landscape.
Methods: An online survey designed to obtain information on each stroke hospital's designation level, most responsible physician for acute reperfusion treatment decision-making, availability of stroke coordinators, stroke research activity and level of transition to tenecteplase for intravenous thrombolysis was distributed to stroke centres in Canada via a network of stroke administrators and physician leads from each province.